financetom
Business
financetom
/
Business
/
LyondellBasell Shows Resilience Despite Big Write-Downs And Weak European Market
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LyondellBasell Shows Resilience Despite Big Write-Downs And Weak European Market
Oct 31, 2025 7:14 AM

LyondellBasell Industries ( LYB ) shares surged after the company delivered stronger-than-expected third-quarter 2025 results, signaling resilience amid a challenging chemical market.

The global chemical giant posted adjusted earnings of $1.01 per share, topping the consensus estimate of 81 cents, and revenue of $7.73 billion, beating expectations of $7.41 billion.

Net loss of $890 million, or $2.77 per diluted share, compared with net income of $115 million, or 34 cents per share, in the prior quarter, investors appeared encouraged by the company’s cost discipline, operational improvements, and outlook for steady cash generation. The quarterly loss included $1.2 billion in non-cash asset write-downs.

Also Read: A Peek at LyondellBasell Industries’ Future Earnings

EBITDA was $(480) million, or $835 million excluding identified items. Operating cash flow totaled $983 million, reflecting a 135% cash conversion rate.

LyondellBasell returned $443 million to shareholders through dividends and ended the quarter with $1.8 billion in cash and $6.5 billion in available liquidity.

In the Olefins and Polyolefins Americas segment, profitability improved due to higher olefins margins and increased volumes following the completion of turnarounds at the Channelview, Texas, facility. Polyethylene spreads narrowed with higher monomer costs, while polypropylene demand remained soft.

In Europe, stronger operations lifted monomer volumes, though polymer pricing was pressured by imports.

The Intermediates and Derivatives segment benefited from higher oxyfuels margins and lower butane prices, partly offset by weaker styrene margins as global supply normalized. A two-month turnaround began in September at the La Porte, Texas, acetyls unit to boost reliability and productivity.

“Our Cash Improvement Plan is on track to achieve our $600 million target in 2025 and a minimum of $1.1 billion by the end of 2026,” CEO Peter Vanacker said. “We are prioritizing an investment-grade balance sheet and safe, reliable operations while creating long-term value for investors.”

LyondellBasell continues its portfolio transformation, securing approvals and signing a purchase agreement for the sale of four European assets.

The Channelview PO/TBA facility exceeded nameplate rates, and the Hyperzone polyethylene plant showed improved performance.

Outlook

The company expects typical year-end seasonality and lower operating rates to weigh on fourth-quarter results. Rising feedstock costs in North America and weak demand in Europe are expected to pressure margins.

LyondellBasell plans to idle its larger cracker in Wesseling, Germany, and a propylene oxide/styrene monomer unit in Channelview, Texas, for about 40 days.

Fourth-quarter operating rates are projected to average 80% for North American O&P assets, 60% for European O&P assets, and 75% for I&D assets.

Price Action: LYB shares were trading higher by 5.81% to $47.82 premarket at last check Friday.

Read Next:

Oil & Gas Giant Chevron Clocks Record Oil Output Thanks To Hess Acquisition

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Prologis raises full-year forecast, cites stabilizing demand
Prologis raises full-year forecast, cites stabilizing demand
Oct 17, 2024
Oct 16 (Reuters) - Real estate investment trust (REIT) Prologis ( PLD ) raised the lower end of its full-year forecast for adjusted core funds from operations on Wednesday due to strong long-term demand drivers, sending its shares up 1.5% in premarket. The warehouse-focused REIT said the decline in business activity, which began after a downturn in freight demand post...
ASML's early earnings publication a 'human mistake', shareholder group says
ASML's early earnings publication a 'human mistake', shareholder group says
Oct 17, 2024
AMSTERDAM (Reuters) - A group of Dutch shareholders on Wednesday reacted with dismay to chip equipment maker's ASML's accidental early publication of its third-quarter earnings, but were also sympathetic to what they called a human mistake. For a company which is the largest listed company in the Netherlands and also the leading technology company in Europe ... it is not...
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
Oct 17, 2024
Novavax Inc. ( NVAX ) stock is trading lower on Wednesday. The FDA has placed a clinical hold on Novavax’s Investigational New Drug (IND) application for its COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates. The clinical hold is due to a spontaneous report of a serious adverse event (SAE) of motor neuropathy in a single CIC Phase 2 trial participant outside...
Novavax's COVID-19-Influenza Vaccine Trial Put on Clinical Hold, Shares Fall
Novavax's COVID-19-Influenza Vaccine Trial Put on Clinical Hold, Shares Fall
Oct 17, 2024
09:18 AM EDT, 10/16/2024 (MT Newswires) -- Novavax ( NVAX ) said Wednesday that the US Food and Drug Administration has placed a clinical hold on its investigational new drug application for its COVID-19-influenza combination and standalone influenza vaccine candidates. The company said the clinical hold is due to a report of a serious adverse event involving motor neuropathy in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved